{"downloaded": true, "htmlmade": false, "full": {"id": "30174329", "source": "MED", "pmid": "30174329", "pmcid": "PMC6119683", "fullTextIdList": {"fullTextId": "PMC6119683"}, "doi": "10.1038/s41368-018-0026-x", "title": "Selective serotonin re-uptake inhibitor sertraline inhibits bone healing in a calvarial defect model.", "authorString": "Howie RN, Herberg S, Durham E, Grey Z, Bennfors G, Elsalanty M, LaRue AC, Hill WD, Cray JJ.", "authorList": {"author": [{"fullName": "Howie RN", "firstName": "R Nicole", "lastName": "Howie", "initials": "RN", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Oral Health Sciences, Medical University of South Carolina, Charleston, SC, USA."}}}, {"fullName": "Herberg S", "firstName": "Samuel", "lastName": "Herberg", "initials": "S", "authorId": {"@type": "ORCID", "#text": "0000-0001-7196-2010"}, "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA."}, {"affiliation": "Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA."}]}}, {"fullName": "Durham E", "firstName": "Emily", "lastName": "Durham", "initials": "E", "authorId": {"@type": "ORCID", "#text": "0000-0002-6322-9393"}, "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Oral Health Sciences, Medical University of South Carolina, Charleston, SC, USA."}}}, {"fullName": "Grey Z", "firstName": "Zachary", "lastName": "Grey", "initials": "Z", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Oral Health Sciences, Medical University of South Carolina, Charleston, SC, USA."}}}, {"fullName": "Bennfors G", "firstName": "Grace", "lastName": "Bennfors", "initials": "G", "authorAffiliationDetailsList": {"authorAffiliation": {"affiliation": "Oral Health Sciences, Medical University of South Carolina, Charleston, SC, USA."}}}, {"fullName": "Elsalanty M", "firstName": "Mohammed", "lastName": "Elsalanty", "initials": "M", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Cellular Biology and Anatomy, Augusta University, Augusta, GA, USA."}, {"affiliation": "Oral Biology, Augusta University, Augusta, GA, USA."}, {"affiliation": "Orthopaedic Surgery, Augusta University, Augusta, GA, USA."}, {"affiliation": "Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, USA."}]}}, {"fullName": "LaRue AC", "firstName": "Amanda C", "lastName": "LaRue", "initials": "AC", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Institute for Regenerative and Reparative Medicine, Augusta University, Augusta, GA, USA."}, {"affiliation": "Research Service of the Ralph H Johnson VA Medical Center, Charleston, SC, USA."}]}}, {"fullName": "Hill WD", "firstName": "William D", "lastName": "Hill", "initials": "WD", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Cellular Biology and Anatomy, Augusta University, Augusta, GA, USA."}, {"affiliation": "Orthopaedic Surgery, Augusta University, Augusta, GA, USA."}, {"affiliation": "Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, USA."}, {"affiliation": "Research Service of the Ralph H Johnson VA Medical Center, Charleston, SC, USA."}, {"affiliation": "Charlie Norwood VA Medical Center, Augusta, GA, USA."}]}}, {"fullName": "Cray JJ", "firstName": "James J", "lastName": "Cray", "initials": "JJ", "authorAffiliationDetailsList": {"authorAffiliation": [{"affiliation": "Oral Health Sciences, Medical University of South Carolina, Charleston, SC, USA. cray.29@osu.edu."}, {"affiliation": "Institute for Regenerative and Reparative Medicine, Augusta University, Augusta, GA, USA. cray.29@osu.edu."}, {"affiliation": "Department of Regenerative Medicine and Cellular Biology, Charleston, SC, USA. cray.29@osu.edu."}, {"affiliation": "Division of Anatomy, College of Medicine, Ohio State University, Columbus, OH, USA. cray.29@osu.edu."}]}}]}, "authorIdList": {"authorId": [{"@type": "ORCID", "#text": "0000-0001-7196-2010"}, {"@type": "ORCID", "#text": "0000-0002-6322-9393"}]}, "dataLinksTagsList": {"dataLinkstag": ["supporting_data", "altmetrics"]}, "journalInfo": {"issue": "3", "volume": "10", "journalIssueId": "2721903", "dateOfPublication": "2018 Sep", "monthOfPublication": "9", "yearOfPublication": "2018", "printPublicationDate": "2018-09-01", "journal": {"title": "International journal of oral science", "ISOAbbreviation": "Int J Oral Sci", "medlineAbbreviation": "Int J Oral Sci", "NLMid": "101504351", "ISSN": "1674-2818", "ESSN": "2049-3169"}}, "pubYear": "2018", "pageInfo": "25", "abstractText": "Bone wound healing is a highly dynamic and precisely controlled process through which damaged bone undergoes repair and complete regeneration. External factors can alter this process, leading to delayed or failed bone wound healing. The findings of recent studies suggest that the use of selective serotonin reuptake inhibitors (SSRIs) can reduce bone mass, precipitate osteoporotic fractures and increase the rate of dental implant failure. With 10% of Americans prescribed antidepressants, the potential of SSRIs to impair bone healing may adversely affect millions of patients' ability to heal after sustaining trauma. Here, we investigate the effect of the SSRI sertraline on bone healing through pre-treatment with (10\u2009mg\u00b7kg<sup>-1</sup> sertraline in drinking water, n\u2009=\u200926) or without (control, n\u2009=\u200930) SSRI followed by the creation of a 5-mm calvarial defect. Animals were randomized into three surgical groups: (a) empty/sham, (b) implanted with a DermaMatrix scaffold soak-loaded with sterile PBS or (c) DermaMatrix soak-loaded with 542.5\u2009ng BMP2. SSRI exposure continued until sacrifice\u00a0in the exposed groups at\u00a04 weeks after surgery. Sertraline exposure resulted in decreased bone healing with significant decreases in trabecular thickness, trabecular number and osteoclast dysfunction while significantly increasing mature collagen fiber\u00a0formation. These findings indicate that sertraline exposure can impair bone wound healing through disruption of bone repair and regeneration while promoting or defaulting to scar formation within the defect site.", "affiliation": "Oral Health Sciences, Medical University of South Carolina, Charleston, SC, USA.", "publicationStatus": "epublish", "language": "eng", "pubModel": "Electronic", "pubTypeList": {"pubType": ["Research Support, Non-U.S. Gov't", "research-article", "Research Support, U.S. Gov't, Non-P.H.S.", "Journal Article", "Research Support, N.I.H., Extramural", "Clinical Trial, Veterinary"]}, "grantsList": {"grant": [{"grantId": "I01 CX000930", "agency": "CSRD VA", "acronym": "CX", "orderIn": "0"}, {"grantId": "T32 DE017551", "agency": "NIDCR NIH HHS", "acronym": "DE", "orderIn": "0"}, {"grantId": "I01 BX000333", "agency": "BLRD VA", "acronym": "BX", "orderIn": "0"}, {"grantId": "P30 GM103331", "agency": "NIGMS NIH HHS", "acronym": "GM", "orderIn": "0"}, {"grantId": "F32 DE024712", "agency": "NIDCR NIH HHS", "acronym": "DE", "orderIn": "0"}, {"grantId": "P01 AG036675", "agency": "NIA NIH HHS", "acronym": "AG", "orderIn": "0"}]}, "meshHeadingList": {"meshHeading": [{"majorTopic_YN": "N", "descriptorName": "Skull", "meshQualifierList": {"meshQualifier": [{"abbreviation": "DG", "qualifierName": "diagnostic imaging", "majorTopic_YN": "N"}, {"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}, {"abbreviation": "IN", "qualifierName": "injuries", "majorTopic_YN": "Y"}]}}, {"majorTopic_YN": "N", "descriptorName": "Animals"}, {"majorTopic_YN": "N", "descriptorName": "Mice, Inbred C57BL"}, {"majorTopic_YN": "N", "descriptorName": "Mice"}, {"majorTopic_YN": "N", "descriptorName": "Sertraline", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "Y"}, {"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"majorTopic_YN": "N", "descriptorName": "Serotonin Uptake Inhibitors", "meshQualifierList": {"meshQualifier": [{"abbreviation": "AE", "qualifierName": "adverse effects", "majorTopic_YN": "Y"}, {"abbreviation": "PD", "qualifierName": "pharmacology", "majorTopic_YN": "N"}]}}, {"majorTopic_YN": "N", "descriptorName": "Enzyme-Linked Immunosorbent Assay"}, {"majorTopic_YN": "N", "descriptorName": "Cell Culture Techniques"}, {"majorTopic_YN": "N", "descriptorName": "Immunohistochemistry"}, {"majorTopic_YN": "N", "descriptorName": "Random Allocation"}, {"majorTopic_YN": "N", "descriptorName": "Wound Healing", "meshQualifierList": {"meshQualifier": {"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}}}, {"majorTopic_YN": "N", "descriptorName": "Apoptosis"}, {"majorTopic_YN": "N", "descriptorName": "Cell Proliferation"}, {"majorTopic_YN": "N", "descriptorName": "Osteogenesis", "meshQualifierList": {"meshQualifier": {"abbreviation": "DE", "qualifierName": "drug effects", "majorTopic_YN": "Y"}}}, {"majorTopic_YN": "N", "descriptorName": "Male"}, {"majorTopic_YN": "N", "descriptorName": "X-Ray Microtomography"}, {"majorTopic_YN": "N", "descriptorName": "Bone Morphogenetic Protein 2"}, {"majorTopic_YN": "N", "descriptorName": "Real-Time Polymerase Chain Reaction"}]}, "chemicalList": {"chemical": [{"name": "bone morphogenetic protein 2", "registryNumber": "0"}, {"name": "Serotonin Uptake Inhibitors", "registryNumber": "0"}, {"name": "BMP2 protein, human", "registryNumber": "0"}, {"name": "Sertraline", "registryNumber": "QUC7NX6WMB"}]}, "subsetList": {"subset": [{"code": "D", "name": "Dentistry journals"}, {"code": "IM", "name": "Index Medicus"}]}, "fullTextUrlList": {"fullTextUrl": [{"availability": "Subscription required", "availabilityCode": "S", "documentStyle": "doi", "site": "DOI", "url": "https://doi.org/10.1038/s41368-018-0026-x"}, {"availability": "Open access", "availabilityCode": "OA", "documentStyle": "html", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC6119683"}, {"availability": "Open access", "availabilityCode": "OA", "documentStyle": "pdf", "site": "Europe_PMC", "url": "https://europepmc.org/articles/PMC6119683?pdf=render"}]}, "isOpenAccess": "Y", "inEPMC": "Y", "inPMC": "N", "hasPDF": "Y", "hasBook": "N", "hasSuppl": "Y", "citedByCount": "4", "hasData": "Y", "hasReferences": "Y", "hasTextMinedTerms": "Y", "hasDbCrossReferences": "N", "hasLabsLinks": "Y", "license": "cc by", "authMan": "N", "epmcAuthMan": "N", "nihAuthMan": "N", "hasTMAccessionNumbers": "N", "dateOfCompletion": "2019-05-10", "dateOfCreation": "2018-09-04", "firstIndexDate": "2018-09-03", "fullTextReceivedDate": "2020-07-11", "dateOfRevision": "2019-05-10", "electronicPublicationDate": "2018-09-03", "firstPublicationDate": "2018-09-03"}, "htmllinks": "https://europepmc.org/articles/PMC6119683", "abstract": "Bone wound healing is a highly dynamic and precisely controlled process through which damaged bone undergoes repair and complete regeneration. External factors can alter this process, leading to delayed or failed bone wound healing. The findings of recent studies suggest that the use of selective serotonin reuptake inhibitors (SSRIs) can reduce bone mass, precipitate osteoporotic fractures and increase the rate of dental implant failure. With 10% of Americans prescribed antidepressants, the potential of SSRIs to impair bone healing may adversely affect millions of patients' ability to heal after sustaining trauma. Here, we investigate the effect of the SSRI sertraline on bone healing through pre-treatment with (10\u2009mg\u00b7kg<sup>-1</sup> sertraline in drinking water, n\u2009=\u200926) or without (control, n\u2009=\u200930) SSRI followed by the creation of a 5-mm calvarial defect. Animals were randomized into three surgical groups: (a) empty/sham, (b) implanted with a DermaMatrix scaffold soak-loaded with sterile PBS or (c) DermaMatrix soak-loaded with 542.5\u2009ng BMP2. SSRI exposure continued until sacrifice\u00a0in the exposed groups at\u00a04 weeks after surgery. Sertraline exposure resulted in decreased bone healing with significant decreases in trabecular thickness, trabecular number and osteoclast dysfunction while significantly increasing mature collagen fiber\u00a0formation. These findings indicate that sertraline exposure can impair bone wound healing through disruption of bone repair and regeneration while promoting or defaulting to scar formation within the defect site.", "pdflinks": "https://europepmc.org/articles/PMC6119683?pdf=render", "journaltitle": "International journal of oral science", "authorinfo": ["Howie RN", "Herberg S", "Durham E", "Grey Z", "Bennfors G", "Elsalanty M", "LaRue AC", "Hill WD", "Cray JJ"], "title": "Selective serotonin re-uptake inhibitor sertraline inhibits bone healing in a calvarial defect model."}